GRM5 and fragile X syndrome: Notably, mGlu5 NAM is considered to be a promising avenue for therapeutic intervention in conditions like Parkinson’s disease [9,10,11], Alzheimer’s disease [12,13,14], neuropathic inflammatory [15,16], and migraine pain [17], as well as Fragile X syndrome [18,19].